Champions Oncology, Inc. Financial Ratios — CSBR Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-45.86	-88.5	-68.16	-72.19	-125.66	-117.21	-99.85	-18.35	1.32	-13.07	1.5	1.74	-15.31	-24.08	16.08
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	13.01	- -	2.34	3.21	- -	- -	- -
Gross Margin (%)	48.98	31.47	35.98	45.77	13.88	22.32	37.04	47.86	47.3	47.08	47.74	51.88	45.18	41.38	50.15
EBITDA Margin (%)	-75.46	-125.33	-72.31	-52.35	-146.95	-90.86	-43.09	-4.91	3.24	-2.37	3.78	4.55	-4.09	-10.08	11.39
Operating Margin (%)	-76.07	-126.8	-74.74	-54.2	-149.36	-92.26	-44.18	-6.69	1	-4.94	0.89	1.24	-8.26	-13.8	8.51
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	23.79	- -	21.89	2.99	- -	- -	173.32
Pretax Margin (%)	-55.09	-121.18	-75.93	-63.97	-146.82	-92.6	-44.55	-7.13	0.85	-6.11	1.06	1.19	-9.78	-14.57	8.12
Profit Margin (%)	-55.25	-121.15	-76.05	-64.12	-148.26	-93.42	-44.67	-7.29	0.47	-6.52	0.88	1.12	-9.9	-14.51	8.26
Net Income to Common Margin (%)	-55.25	-121.15	-76.05	-64.12	-148.26	-93.42	-44.67	-7.29	0.47	-6.52	0.88	1.12	-9.9	-14.51	8.26
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	44.59	- -	17.16	6	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	10	9	9	7	6
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1	1	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	9	8	7	6	5
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.04	0.02	-4.99	6.19	4.24	-3.9	-1.47	0.94
Net Debt/EBITDA	2.01	0.53	1.59	0.97	0.72	0.25	0.5	0.86	-3.7	10.96	-3.02	-4.03	4.59	0.52	-1.51
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.03	0.06	-2.39	26.23	15.59	-1.93	-1.07	1.26
Net Debt/EBIT	2	0.52	1.54	0.94	0.71	0.25	0.48	0.63	-11.99	5.26	-12.81	-14.84	2.27	0.38	-2.02
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-130	-362.68	-269.8	-437.69	-431.73	-1,081.13	-865.55	-876.64	-627.48	-351.21	-262.83	-203.43	-225.3	-323.66	-246.96
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	566.67	- -	62.17	118.24	92.48	159.43	- -	122.85
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.02	- -	-4.59	-13.96	-13.46	-10.76	-7.9	-6.28
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.21	- -	15.28	31.83	23.78	21.54	23.32	14.33
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	1,433.33	0.71	74.49	129.25	104.07	185.48	-390.44	161.85
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.06	-0.02	-5.5	-15.26	-15.15	-12.52	-9.63	-8.28
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.53	0.14	18.3	34.8	26.76	25.06	28.43	18.88
Net Debt to Equity	-55,036.84	-165.01	-124.56	-184.27	-116.11	-1,086.13	-823.75	-28,533.33	-144.64	-163.6	-63.1	-99.02	-218.25	137.57	-259.41
Net Debt/Capital (%)	38.87	15.92	23.32	13.18	15.25	3.97	4.54	1.2	4.38	10.77	6.93	12.6	12.84	3.28	11.71
EBITDA	-5	-9	-6	-6	-13	-10	-7	-1	1	-1	2	2	-2	-5	6
EBITDA-CapEx	-5	-9	-6	-6	-13	-10	-7	-2	- -	-3	-2	- -	-5	-6	6
Operating Income (Loss)	-5	-9	-6	-6	-13	-10	-7	-1	- -	-2	- -	1	-4	-7	5

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Cash Ratio	2.99	1.36	3.26	1.61	2.46	0.49	0.44	0.11	0.4	0.68	0.42	0.52	0.47	0.12	0.41
Current Ratio	3.38	1.59	3.54	2.08	2.84	0.82	0.79	0.68	0.99	1.1	1.13	1.13	0.9	0.63	0.94
Quick Ratio	3.3	1.53	3.43	1.97	2.74	0.73	0.75	0.64	0.95	1.07	1.04	1.06	0.83	0.56	0.88
CFO/Avg Current Liab	-0.02	-1.5	-1.34	-1.04	-2.58	-1.41	-0.45	-0.16	0.24	0.29	-0.14	0.45	0.2	-0.28	0.33
Common Equity/Total Assets	-130	-362.68	-269.8	-437.69	-431.73	-1,081.13	-865.55	-876.64	-627.48	-351.21	-262.83	-203.43	-225.3	-323.66	-246.96
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	566.67	- -	62.17	118.24	92.48	159.43	- -	122.85
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.02	- -	-4.59	-13.96	-13.46	-10.76	-7.9	-6.28
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.21	- -	15.28	31.83	23.78	21.54	23.32	14.33
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	1,433.33	0.71	74.49	129.25	104.07	185.48	-390.44	161.85
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.06	-0.02	-5.5	-15.26	-15.15	-12.52	-9.63	-8.28
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	0.53	0.14	18.3	34.8	26.76	25.06	28.43	18.88
CFO/Total Liabilities	-0.43	-129.35	-108.23	-60.55	-241.47	-115.69	-37.31	-15.18	20.63	18.56	-8.34	24.72	13.39	-21.89	25.85
CFO/CapEx	-0.64	-10.07	-75.47	-14.67	-80.92	-19.9	-3.71	-1	2.23	1.31	-0.51	2.73	1.38	-7.34	18.99
Altman's Z-Score	-0.35	-4.22	-1.62	-0.73	0.86	-18.19	-12.15	-8.1	0.13	-0.11	2.08	0.97	-0.77	-2.49	0.78

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Accounts Receivable Turnover	20.42	13.25	20.47	30.31	20.4	19.4	10.27	9.85	14.17	13.86	11.79	9.5	10.9	11.49	9.69
Days Sales Outstanding	17.87	27.54	17.83	12.04	17.89	18.82	35.54	37.07	25.75	26.34	30.95	38.43	33.47	31.76	37.66
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	2.78	3.01	3.7	5.73	6.37	5.25	5.18	5.27	5.75	5.72	8.52	9.93	7.2	5.28	5.65
Accounts Payable Turnover Days	131.2	121.29	98.65	63.67	57.26	69.55	70.49	69.28	63.47	63.84	42.84	36.77	50.69	69.11	64.59
Cash Conversion Cycle	-113.32	-93.75	-80.82	-51.63	-39.37	-50.73	-34.96	-32.21	-37.72	-37.5	-11.89	1.65	-17.21	-37.35	-26.93
Inventory to Cash Days	17.87	27.54	17.83	12.04	17.89	18.82	35.54	37.07	25.75	26.34	30.95	38.43	33.47	31.76	37.66
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Market Capitalization	34	31	18	61	64	34	29	48	103	91	141	101	67	66	98
- Cash & Cash Equivalents	10	5	10	6	9	3	3	1	3	8	5	9	10	3	10
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	10	9	9	7	6
Enterprise Value	23	27	8	55	54	31	26	47	100	87	146	102	65	71	94
Total Capital	-16	-25	-31	-39	-52	-62	-69	-71	-71	-69	-63	-63	-69	-77	-74
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	-0.06	-0.02	-5.5	-15.26	-15.15	-12.52	-9.63	-8.28
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.04	0.07	0.09	0.13	0.11	0.06
EV/Sales	3.39	3.72	0.99	4.76	6.13	2.77	1.67	2.32	3.69	2.7	3.55	2.07	1.21	1.41	1.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	113.87	- -	94.13	45.57	- -	- -	14.49
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	369.44	- -	398.62	167.73	- -	- -	19.39
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	53.57	29.91	- -	15.67	16.39	- -	12.73
EV/Free Cash Flow to Firm	752.16	- -	- -	- -	- -	- -	- -	15,629.4	37	16.95	91.18	11.46	9.51	- -	12.09
Diluted Market Cap	34	31	18	61	64	34	29	48	128	91	156	109	67	66	102
Diluted Enterprise Value	23	27	8	55	54	31	26	47	125	87	161	109	65	71	98
EV per Share	8.28	6.82	2.78	9.86	6.24	3.55	2.35	4.26	8.8	7.34	11.1	7.71	4.81	5.21	6.88
TTM Sales	7	7	8	12	9	11	15	20	27	32	41	49	54	50	57
TTM EBITDA	-5	-9	-6	-6	-13	-10	-7	-1	1	-1	2	2	-2	-5	6
TTM Operating Income	-5	-9	-6	-6	-13	-10	-7	-1	- -	-2	- -	1	-4	-7	5
TTM Cash Flow to Firm	- -	-5	-4	-3	-10	-6	-3	-1	2	3	-2	6	4	-6	7
TTM Free Cash Flow to Firm	- -	-5	-4	-3	-10	-6	-2	- -	3	5	2	9	7	-5	8

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Price/Free Cash Flow	1,089.48	-6.66	-4.2	-19.03	-6.7	-5.51	-14.03	15,900.4	47.48	17.84	97.73	12.24	9.73	-12.39	13.12
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	369.44	- -	398.62	167.73	- -	- -	19.39
Enterprise Value	23	27	8	55	54	31	26	47	100	87	146	102	65	71	94
Low Price	4.8	7.44	2.52	5.16	2.4	3.22	1.11	2.28	3.92	4.02	7.05	7.06	3.75	4.17	3.6
EV/Sales	3.39	3.72	0.99	4.76	6.13	2.77	1.67	2.32	3.69	2.7	3.55	2.07	1.21	1.41	1.65
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	113.87	- -	94.13	45.57	- -	- -	14.49
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	804.44	- -	389.45	184.95	- -	- -	20.78
Price/Earnings Average	-7.93	-4.29	-2.6	-9.91	-5.51	-4.22	-4.12	-24.8	811.22	-39.55	368.03	220.04	-16.42	-10.69	18.55
Price/Earnings High	-11.1	-6.49	-3.83	-17.97	-8.34	-7.5	-7.64	-35.41	1,585.85	-59.08	532.82	270.93	-25.08	-13.63	34.84
Price/Earnings Low	-3.55	-3.35	-1.18	-3.88	-1.59	-2.68	-1.77	-17	347.29	-22.75	255.88	170.02	-9.52	-7.76	10.46
Price/Book Value	-2.05	-1.25	-0.57	-1.57	-1.22	-0.54	-0.42	-0.67	-1.46	-1.25	-1.94	-1.41	-0.86	-0.78	-1.22
Price/Book Value Average	-1.83	-1.48	-0.52	-1.89	-1.39	-0.71	-0.41	-0.52	-1.47	-1.14	-1.84	-1.68	-1.13	-0.92	-1.09
Price/Book Value High	-2.57	-2.24	-0.77	-3.43	-2.11	-1.25	-0.76	-0.74	-2.87	-1.7	-2.66	-2.06	-1.73	-1.17	-2.05
Price/Book Value Low	-0.82	-1.16	-0.24	-0.74	-0.4	-0.45	-0.18	-0.35	-0.63	-0.65	-1.28	-1.29	-0.66	-0.67	-0.62
Price/Tangible Book Value	-51.96	14.18	2.54	24.08	8.62	-77.76	-108.19	-71.62	65.63	19.19	19.88	11.57	15.49	-29.36	28.42
Price/Tangible Book Value Average	-46.36	16.8	2.35	29.03	9.8	-102.3	-105.32	-54.96	66.18	17.38	18.78	13.76	20.37	-34.75	25.37
Price/Tangible Book Value High	-64.95	25.4	3.46	52.65	14.84	-181.77	-195.56	-78.48	129.37	25.95	27.19	16.95	31.11	-44.31	47.65
Price/Tangible Book Value Low	-20.78	13.12	1.07	11.38	2.83	-65.03	-45.32	-37.67	28.33	9.99	13.06	10.63	11.81	-25.24	14.31
Price/Sales	4.91	4.39	2.14	5.27	7.19	3	1.89	2.36	3.8	2.85	3.44	2.06	1.24	1.31	1.72
Price/Sales Average	4.38	5.2	1.98	6.35	8.17	3.94	1.84	1.81	3.84	2.58	3.25	2.46	1.63	1.55	1.53
Price/Sales High	6.13	7.86	2.91	11.52	12.37	7.01	3.41	2.58	7.5	3.85	4.7	3.02	2.48	1.98	2.88
Price/Sales Low	1.96	4.06	0.9	2.49	2.36	2.51	0.79	1.24	1.64	1.48	2.26	1.9	0.94	1.13	0.86
Price/Cash Flow	-625.44	-6	-4.14	-17.73	-6.61	-5.23	-10.25	-38.91	55.3	31.47	-83.87	15.6	16.77	-10.71	13.22
Price/Cash Flow Average	-557.98	-7.11	-3.82	-21.37	-7.52	-6.88	-9.98	-29.85	55.77	28.5	-79.25	18.56	22.06	-12.67	11.8
Price/Cash Flow High	-781.8	-10.75	-5.63	-38.77	-11.39	-12.23	-18.52	-42.63	109.02	42.56	-114.74	22.85	33.68	-16.16	22.17
Price/Cash Flow Low	-250.18	-5.55	-1.74	-8.38	-2.17	-4.37	-4.29	-20.46	23.87	16.39	-55.1	14.34	12.78	-9.21	6.66
Price/Free Cash Flow Average	971.97	-7.89	-3.87	-22.94	-7.61	-7.24	-13.66	12,200.23	47.87	16.15	92.36	14.57	12.8	-14.67	11.71
Price/Free Cash Flow High	1,361.85	-11.93	-5.71	-41.61	-11.53	-12.87	-25.36	17,421.78	93.59	24.13	133.71	17.94	19.55	-18.71	22
Price/Free Cash Flow Low	435.79	-6.17	-1.76	-8.99	-2.2	-4.61	-5.88	8,362.45	20.5	9.29	64.21	11.26	7.42	-10.66	6.61
EV/Sales Average	2.86	4.53	0.83	5.84	7.11	3.71	1.62	1.77	3.72	2.44	3.37	2.46	1.6	1.65	1.47
EV/Sales High	4.61	7.19	1.76	11.01	11.32	6.78	3.2	2.54	7.38	3.71	4.82	3.03	2.46	2.07	2.81
EV/Sales Low	0.44	3.4	- -	1.98	1.3	2.28	0.58	1.2	1.52	1.34	2.38	1.91	0.91	1.22	0.8
EV/EBITDA Average	-3.79	-3.62	-1.14	-11.16	-4.84	-4.09	-3.77	-36	114.86	-102.81	89.12	54.18	-39.08	-16.34	12.87
EV/EBITDA High	-6.12	-5.74	-2.44	-21.04	-7.7	-7.46	-7.43	-51.76	228.05	-156.51	127.61	66.66	-60.04	-20.57	24.68
EV/EBITDA Low	-0.59	-2.71	0.34	-3.78	-0.89	-2.5	-1.34	-24.42	47.07	-56.59	62.93	41.91	-22.36	-12.13	7.01
EV/EBIT Average	-3.76	-3.57	-1.11	-10.78	-4.76	-4.02	-3.68	-26.43	372.65	-49.33	377.43	199.41	-19.35	-11.93	17.23
EV/EBIT High	-6.07	-5.67	-2.36	-20.32	-7.58	-7.34	-7.24	-38	739.88	-75.1	540.42	245.35	-29.73	-15.02	33.04
EV/EBIT Low	-0.58	-2.68	0.33	-3.65	-0.87	-2.47	-1.31	-17.93	152.71	-27.15	266.51	154.25	-11.07	-8.86	9.39
Last Price	12	8.04	6	10.92	7.32	3.85	2.65	4.34	9.08	7.72	10.73	7.68	4.92	4.85	7.15
High Price	15	14.4	8.16	23.88	12.6	9	4.79	4.75	17.9	10.44	14.68	11.25	9.88	7.32	11.99
Enterprise Value Average	20	32	7	67	63	42	25	36	101	78	138	121	86	83	84
Enterprise Value High	32	51	15	127	100	76	49	51	200	119	198	149	132	104	160
Enterprise Value Low	3	24	-2	23	12	25	9	24	41	43	98	94	49	61	45

Shares Outstanding	3	3	3	6	9	9	11	11	12	13	13	14	14	14	14
Diluted Weighted Avg Shares	3	4	3	6	9	9	11	11	14	12	15	14	14	14	14
Basic Weighted Avg Shares	3	4	3	6	9	9	11	11	11	12	13	13	14	14	14
Revenue per Share	2.45	1.83	2.8	2.07	1.02	1.28	1.4	1.84	2.39	2.71	3.12	3.72	3.98	3.7	4.17
EBITDA per Share	-1.85	-2.3	-2.03	-1.08	-1.5	-1.17	-0.6	-0.09	0.08	-0.06	0.12	0.17	-0.16	-0.37	0.47
Operating Income per Share	-1.86	-2.32	-2.09	-1.12	-1.52	-1.19	-0.62	-0.12	0.02	-0.13	0.03	0.05	-0.33	-0.51	0.35
Basic EPS, GAAP	-1.35	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.03	0.04	-0.39	-0.54	0.34
Basic EPS from Cont Ops	-1.35	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.03	0.04	-0.39	-0.54	0.34
Diluted EPS, GAAP	-1.35	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.02	0.04	-0.39	-0.54	0.33
Diluted EPS from Cont Ops	-1.35	-2.22	-2.13	-1.33	-1.51	-1.2	-0.63	-0.13	0.01	-0.18	0.02	0.04	-0.39	-0.54	0.33
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.02	-1.34	-1.45	-0.62	-1.11	-0.74	-0.26	-0.11	0.16	0.25	-0.13	0.49	0.29	-0.45	0.54
Free Cash Flow per Basic Share	-0.05	-1.47	-1.47	-0.66	-1.12	-0.77	-0.33	-0.22	0.09	0.06	-0.38	0.31	0.08	-0.51	0.51
Cash & Equivalents per Share	3.72	1.22	3.22	1.06	1.08	0.3	0.3	0.08	0.29	0.7	0.36	0.68	0.75	0.19	0.72
Book Value per Share	-5.84	-6.44	-10.58	-6.96	-5.98	-7.17	-6.31	-6.44	-6.23	-6.15	-5.52	-5.45	-5.71	-6.24	-5.85
Tangible Book Value per Share	-0.23	0.57	2.36	0.45	0.85	-0.05	-0.02	-0.06	0.14	0.4	0.54	0.66	0.32	-0.17	0.25

Champions Oncology, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)